Magnesium Sulfate vs Placebo for Placental Abruption

Completed · Not applicable · Has a placebo group

Conditions studied: Abruptio Placentae

In brief

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Key facts

Study ID

NCT00186069

Run by

Stanford University

People needed

30

Starts

2004-03-01

Expected to finish

2017-11-01

Last updated by the study team

2018-01-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.

You may not qualify if…

• preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress

Where it is running

• Santa Clara Valley Medical Center — San Jose, California, United States
• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.